Gp100, tyrosinase, and TRP-2 were identified previously as melanoma antigens recognized by cytotoxic T cells from cancer patients, and TRP-1 was identified as a melanoma antigen recognized by IgG antibodies in the serum of a melanoma patient [24]. Here, TYR is linked to cancer.